
本站推荐电影
本站推荐电视剧
电影下载排行
电视剧下载排行

A | Shares of Pfizer are in retreat on the first day of trading after the drug company said sales of its COVID-19 vaccine and its coronavirus treatment are weaker than it had expected and cut revenue projections by $9 billion for the year. Falling sales of both clipped sales in the second quarter, but Pfizer said in August that it expected a rebound in the second half of 2023. Shares of Pfizer slipped more than 1% before the opening bell Monday and Moderna, which is heavily reliant on the competing vaccine it makes, slid nearly 5%. Pfizer said Friday that global usage of Paxlovid is trending slightly above last year, but that it's still below expectations.The fall vaccination period just began and the New York City drugmaker said that it's too soon to get a handle on vaccination rates for the year.Full-year revenue for Paxlovid and Comirnaty is expected to be approximately $12.5 billion, short $9 billion of what it had expected. Pfizer is lowering its full-year revenue expectations for Paxlovid by approximately $7 billion. That number also accounts for delayed commercialization of the product, which was pushed to January 2024 from the company's previous expectation of commercialization in the second half of this year. Pfizer is also lowering its 2023 revenue expectations for Comirnaty by approximately $2 billion due to lower-than-expected vaccination rates.Pfizer Inc. now foresees 2023 revenue in a range of $58 billion to $61 billion, down from its prior forecast for $67 billion to $70 billion. It now projects full-year adjusted earnings between $1.45 and $1.65 per share due to lower-than-anticipated revenue for COVID-19-related products and inventory write-offs.That is short of the full-year revenue of $63.61 billion and earnings of $2.77 per share that Wall Street was expecting, and far short of the company's previous projections of per-share earning between $3.25 and $3.45. JPMorgan said the company's update solves an ongoing U.S. Paxlovid inventory debate and it anticipates the company's bigger-than-expected cuts to its sales projections will help put a floor under per-share earnings expectations for next year.。1月8日下午,雷军个人账户关注一个问题:为什么华为是一个民族品牌,而小米不是一个民族自豪感?然而,雷军暂时没有回答这个问题。他希望网民们能阅读或回答。

B | 在这个问题下,网友们讨论得很激烈。一些网友认为这个话题有问题。最初的问题是:“为什么华为是一个民族品牌,而在印度占有第一市场份额的小米不是民族自豪感?”经过几次修改,一些描述被删除了。据新浪科技1月10日下午的新闻报道,雷军在接受媒体采访时回应了近期的担忧。雷军说:“你知道这个账户是我开的吗?也许我没有开任何账户。我过去一年不知道。这真的和我无关。Redmi今天正式发布了其首款手机Red Rice Note 7,这是Redmi的一个新独立品牌,并预测了Red Rice Note 7Pro的浪潮。雷军在官方微博下正式确认,红米系列也将迎来555旗舰手机。

C | 根据小米2018年第三季度的最新财务报告,小米集团的单季智能手机出货量达到3330万台,稳定了高端市场;海外收入增长112.7%,占总收入的43.9%;互联网服务收入同比增长85.5%;前三季度的物联网和消费品收入谷子电视销量同比增长198.5%。
Current article:http://km339m.feishuozhuangkeqi.cyou/7zfg/20260826/264.html
Published on:13:07:02